Endothelin and cardiovascular remodelling in end-stage renal disease

Nephrology Dialysis Transplantation

Volumn 13, Issue 2, 1998, Pages 375-383

  Demuth, Karine ^a   Blacher, Jacques ^b   Guerin, Alain P ^c   Benoit, Marie Odile ^a   Moatti, Nicole ^a   Safar, Michel E ^b   London, Gérard M ^c  

^a HÔPITAL BROUSSAIS   (France)

^b INSERM   (France)

^c Hopital Manhes   (France)

Author keywords

Cardiovascular remodelling; Endothelin; ESRD

Indexed keywords

ENDOTHELIN; HEMOGLOBIN;

ADULT; ARTERY INTIMA PROLIFERATION; ARTICLE; ATHEROSCLEROTIC PLAQUE; BLOOD LEVEL; BLOOD PRESSURE; BODY SIZE; CARDIOVASCULAR SYSTEM; COMMON CAROTID ARTERY; CONTROLLED STUDY; ENZYME IMMUNOASSAY; FEMALE; FOREARM BLOOD FLOW; GENDER; HEART LEFT VENTRICLE; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; KIDNEY FAILURE; MALE; PRIORITY JOURNAL; PULSE WAVE; VASODILATATION; VEIN OCCLUSION PLETHYSMOGRAPHY;

EID: 0031965359     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.ndt.a027833     Document Type: Article

References (66)

1. Raine AEG, Margreiter R, Brunner FP. et al. Report on management of renal failure in Europe, XXII, 1991. Nephrol Dial Transplant [Suppl.2], 1992; 7: 1-48
2. London GM, Marchais SJ, Guérin AP, Fabiani F, Métivier F. Cardiovascular function in hemodialysis patients. In: Grünfeld JP, Bach JF, Funck-Brentano JL, Maxwell MH. (eds) Advances in Nephrology. Vol. 20. St Louis, Mosby Year Book, 1991, pp. 249-273
3. Barenbrock M, Spieker C, Laske V, Rahn K-H. Studies of the vessel wall properties in hemodialysis patients. Kidney Int 1994; 45: 1397-1400
4. London GM, Guérin AP, Marchais SJ et al. Cardiac and arterial interactions in end-stage renal disease. Kidney Int 1996; 50: 600-608
5. Lindner A, Charra B, Sherrard D, Scribner BM. Accelerated atherosclerosis in prolonged maintenance hemodialysis. N Engl J Med 1974; 290: 697-702
6. Yanagisawa M, Kurihara H, Kimura S. et al. A novel potent vasoconstrictor peptide produced by endothelial cells. Nature 1988; 332: 411-415
7. Miller W, Redfield M, Burnett JC Jr. Integrated cardiac, renal and endocrine actions of endothelin. J Clin Invest 1989; 83: 317-320
8. + exchange, c-fos expression, and mitogenesis in rat mesangial cells. J Clin Invest 1989; 83: 708-712
9. Dubin D, Pratt RE, Cooke JP, Dzau VJ. Endothelin, a potent vasoconstrictor, is a vascular smooth muscle mitogen. J Vasc Med Biol 1989; 1: 150-154
10. Hirata Y, Takagi Y, Fukuda Y, Marumo F. Endothelin is a potent mitogen for rat vascular smooth muscle cells. Atherosclerosis 1989; 78: 225-228
11. McMurray JJ, Ray SG, Abdullah I, Dargie HJ, Morton JJ. Plasma endothelin in chronic heart failure. Circulation 1992; 85: 1374-1379
12. Wei CH, Lerman A, Rodeheffer RJ et al. Endothelin in human congestive heart failure. Circulation 1994; 89: 1580-1586
13. Steward DJ, Kubac G, Costello KB, Cernacek P. Increased plasma endothelin-1 in the early h of acute myocardial infarction. J Am Coll Cardiol 1991; 18: 38-43
14. Lerman A, Edwards BS, Hallett JW, Heublein DM, Sandberg SM, Burnett JC Jr. Circulating and tissue endothelin immunoreactivity in advanced atherosclerosis. N Engl J Med 1991; 325: 997-1001
15. Dohi Y, Lüscher TF. Endothelin in hypertensive resistant arteries. Intraluminal and extraluminal dysfunction. Hypertension 1991; 18: 543-549
16. Koyama Y, Tabata T, Nishzawa Y, Inoue T, Morii H, Yamaji T. Plasma endothelin levels in patients with uraemia. Lancet 1989; i: 991-992
17. Warrens AN, Cassidy MJD, Takahashi K, Ghatei MA, Bloom SR. Endothelin in renal failure. Nephrol Dial Transplant 1990; 5: 418-422
18. Wilkie ME, Khandan-Nia N, Ghatei MA, Bloom SR, Raftery MJ, Cunningham J. Does the arteriovenous fistula in chronic haemodialysis patients stimulate endothelin-1 release? Nephrol Dial Transplant 1992; 7: 1019-1021
19. Niwa T, Fujishiro T, Uema K. et al. Effect of hemodialysis on plasma levels of vasoactive peptides, endothelin, calcitonin-gene related peptide and human atrial natriuretic peptide. Nephron 1993; 64: 552-559
20. Mallamaci F, Parlongo S, Zoccali C. Influence of cardiovascular damage and residual renal function on plasma endothelin in chronic renal failure. Nephron 1993; 63: 291-295
21. Sahn DJ, De Maria A, Kisslo J, Weyman A. Recommendations regarding quantitation in M-mode echocardiographic measurements. Circulation 1978; 58: 1072-1083
22. Devereux RB, Reichek N. Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method. Circulation 1977; 55: 613-618
23. Hoeks APG, Brands PJ, Smeets FA, Reneman RS. Assessment of distensibility of superficial arteries. Ultrasound Med Biol 1990; 16: 121-128
24. Bonithon-Kopp C, Ducimetière P, Touboul JP, Fève JM, Billaud E, Courbon D, Héraud V. Plasma converting-enzyme activity and carotid wall thickening. Circulation 1994; 89; 952-954
25. Avolio AO, Chen SG, Wang RP. Zhang Cl, Li MF, O'Rourke MF. Effects of aging on changing arterial compliance and left ventricular load in a Northern Chinese urban community. Circulation 1983; 68: 50-58
26. Sumner DS. Volume plethysmography in vascular disease. An overview. In: Bernstein EF (ed.) Noninvasive Diagnostic Techniques in Vascular Disease. 3rd edn. C. V. Mosby, St Louis, 1985: 97-118
27. Battistini B, D'Orleans-Juste P, Sirois P. Endothelins. Circulating plasma levels and presence in other biologic fluids. Lab Invest 1993; 68: 600-628
28. Benigni A, Perico N, Gaspari F. et al. Increased renal endothelin production in rats with reduced renal mass. Am J Physiol 1991; 260: F331-F339
29. Orisio S, Benigni A, Bruzzi I. et al. Renal endothelin gene expression is increased in remnant kidney and correlates with disease progression. Kidney Int 1993; 43: 354-358
30. Ohte K, Hirata Y, Shichiri M. et al. Urinary excretion of endothelin-1 in normal subjects and patients with renal disease. Kidney Int 1991; 39: 307-311
31. Kohno M, Yasunari K, Murakawa KI. et al. Plasma immunoreactive endothelin in essential hypertension. Am J Med 1990; 88: 614-618
32. Stockenhuber F, Gottsauner-Wolf M, Marosi L, Liebisch B, Kurz RW, Balcke P. Plasma levels of endothelin in chronic renal failure and cyclosporin A-associated nephrotoxicity. Clin Sci 1992; 82: 255-258
33. Shichiri M, Hirata Y, Ando K. et al. Plasma endothelin levels in hypertension and chronic renal failure. Hypertension 1990; 15: 493-496
34. Salto Y, Kazuwa N, Shirakami G. et al. Endothelin in patients with chronic renal failure. J Cardiovasc Pharmacol 1991; 17 [Suppl 7]: S437-S439
35. Pernow WJ, Hemsen A, Lundberg JM. Tissue specific distribution, clearance and vascular effects of endothelin in the pig. Biochem Biophys Res Commun 1989; 161: 647-653
36. Kohno M, Murakawa K, Yasunari K. et al. Prolonged blood pressure elevation after endothelin administration in bilaterally nephrectomized rats. Metabolism 1989; 38: 712-713
37. Yoshizumi M, Kurihara H, Sugiyama T. et al. Hemodynamic shear stress stimulates endothelin production by cultured endothelial cells. Biochem Biophys Res Commun 1989; 161: 859-864
38. Sumpio BE, Widmann MD. Enhanced production of endothelium-derived contracting factor by endothelial cells subjected to pulsatile stretch. Surgery 1990; 108: 277-281
39. Kuchan MJ, Frangos JA . Shear stress regulates endothelin-1 release via protein kinase C and cGMP in cultured endothelial cells. Am J Physiol 1993; 264: H150-H156
40. Malek AM, Greene AL, Izumo S. Regulation of endothelin-1 gene by fluid shear stress is transcriptionally mediated and indépendant of protein kinase C and cAMP. Proc Natl Acad Sci USA 1993; 90: 5999-6003
41. Wang DL, Wung BS, Peng YC, Wang JJ. Mechanical strain increases endothelin-1 expression via protein kinase C pathway in human endothelial cells. J Cell Physiol 1995; 163: 400-406
42. Hishikawa X, Nakaki T, Marumo T, Suzuki H, Kato R, Saruta T. Pressure enhances endothelin-1 release from cultured human endothelial cells. Hypertension 1995; 25: 449-452
43. Marchais SJ, Guérin AP, Pannier BM, Levy BI, Safar ME, London GM. Wave reflections and cardiac hypertrophy in chronic uremia. Influence of body size. Hypertension 1993; 22: 876-883
44. London GM, Guérin AP, Pannier B, Marchais SJ, Benetos A, Safar ME. Increased systolic pressure in chronic uremia. Role of arterial wave reflections. Hypertension 1992; 20. 10-19
45. Fellner SK, Lang RM, Neumann A, Korcarz C, Borow K. Cardiovascular consequences of correction of the anemia of renal failure with erythropoietin. Kidney Int 1993; 44: 1309-1315
46. London GM, Pannier B, Guérin AP, Marchais SJ, Safar ME, Cuche JL. Cardiac hypertrophy, aortic compliance, peripheral resistance, and wave reflection in end-stage renal disease. Comparative effects of ACE inhibition and calcium channel blockade. Circulation 1994; 90: 2786-2796
47. Ito H, Hirata Y, Hiroe M. et al. Endothelin-1 induces hypertrophy with enhanced expression of muscle-specific genes in cultured neonatal rat cardiomyocytes. Circ Res 1991; 69: 209-215
48. Moraves CS, Reynolds EE, Steward RW, Bond M. Endothelin is a positive inotropic agent in human and rat heart in vivo. Biochem Biophys Res Commun 1989; 159: 14-18
49. Sakai S, Miyauchi T, Sakurai T. et al. Endogenous endothelin-1 participates in the maintenance of cardiac function in rats with congestive heart failure. Marked increase in endothelin-1 production in the failing heart. Circulation 1996; 93: 1214-1222
50. Arai M, Yoguchi A, Iso T. et al. Endothelin-1 and its binding sites are upregulated in pressure overload cardiac hypertrophy. Am J Physiol 1995; 268: H2084-H2091
51. Brown LA, Nunez DJ, Brookes CI, Wilkins MR. Selective increase in endothelin-1 and endothelin A receptor subtype in the hypertrophied myocardium of the aorto-venocaval fistula rat. Cardiovasc Res 1995; 29: 768-774
52. Ito H, Hirata Y, Adachi S. et al. Endothelin-1 is an autocrine/ paracrine factor in the mechanism of angiotensin II-induced hypertrophy in cultured rat cardiomyocytes. J Clin Invest 1993; 92: 398-403
53. Jones GT, Vanrij AM, Solomon C, Thomson IA, Packer SGK. Endothelin-1 is increased overlying atherosclerotic plaques in human arteries. Atherosclerosis 1996; 124: 25-35
54. Gris JC, Branger B, Vecina F, Al Sabadini B, Fourcade J, Schved JF. Increased cardiovascular risk factors and features of endothelial activation and dysfunction in dialyzed uremic patients. Kidney Int 1994; 46: 807-813
55. Joannides R, Bakkali ELH, Le Roy F. et al. Altered nitric oxide pathway in large peripheral arteries of hemodialysis patients. J Hypertens 1996; 14 [Suppl. 1]: S121 [abstr.]
56. Vallance P, Leone A, Calver A, Collier J, Moncada S. Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure. Lancet 1992; 339: 572-575
57. Arese M, Strasly M, Ruva C. et al. Regulation of nitric oxide synthesis in uraemia. Nephrol Dial Transplant 1995; 10: 1386-1397
58. Boulanger C, Lüscher TF. Release of endothelin from the porcine aorta. Inhibition of endothelium-derived nitric oxide. J Clin Invest 1990; 85: 587-590
59. Sainjonmaa O, Ristimaki A, Fyhrquist F. Atrial natriuretic peptide, nitroglycerine, and nitroprusside reduce basal and stimulated endothelin production from cultured endothelial cells. Biochem Biophys Res Commun 1990; 173: 514-520
60. Schini VB, Hendrickson H, Heiblein DM, Burnett JC Jr. Vanhoutte PM. Thrombin enhances the release of endothelin from cultured porcine aortic endothelial cells. Eur J Pharmacol 1989; 165: 333-334
61. Ohta K, Hirata Y, Imai T. et al. Cytokine-induced release of endothelin-1 from porcine renal epithelial cell line. Biochem Biophys Res Commun 1990; 169: 578-584
62. Yoshizumi M, Kurihara H, Morita T. et al. Interleukin-1 increases the production of endothelin-1 by cultured endothelial cells. Biochem Biophys Res Commun 1990; 166: 324-329
63. Kurihara H, Yoshizumi M, Sugiyama T. et al. Transforming growth factor-β stimulates the expression of endothelin mRNA by vascular endothelial cells. Biochem Biophys Res Commun 1989; 159: 1435-1440
64. Wagner OF, Christ G, Wojta J. et al. Polar secretion of endothelin-1 by cultured endothelial cells. Proc Natl Acad Sci USA 1992; 267: 10066-16067
65. Emori T, Hirata Y, Ohta K, Shichiri M, Marumo F. Secretory mechanisms of immunoreactive endothelin in cultured bovine endothelial cells. Biochem Biophys Res Commun 1989; 160: 93-100
66. Vane JR, Anggard EE, Botting RM. Mechanisms of disease Regulatory functions of the vascular endothelium. N Engl J Med 1990; 323: 27-36